Jun 2026 (Q2 FY26) — Aug 5, 2026
Palomar Holdings Q2 FY26 — Record Adjusted Net Income & Increased Full-Year Guidance
Read the full callPalomar Holdings (PLMR) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Palomar Holdings earnings: last reported Wed, 5 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 314 | +54.7% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | Operating profit / revenue | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. | ||
| Net profit | 52.6 | +13.0% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$137.61 +0.63% · +$0.86
Performance +15.2% 1Y
1Y: $119.48 on 14 Oct 2025 → $137.61. High $145.29 (7 Jul 2026), low $101.42 (3 Jun 2026).
- Previous close
- $136.75
- 52-week range
- $101.42 – $145.29
- One year
- +16.97%
Overview
- Symbol
- PLMR
- Sector
- Financials
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Palomar Holdings earnings calls (PLMR)
Financials
What the filings say
Net profit, year on year: +13% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 149 | 156 | 175 | 203 | 245 | 253 | 279 | 314 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 5 |
| Profit before tax | 39 | 45 | 54 | 60 | 67 | 73 | 53 | 70 |
| Tax rate | 20.8% | 22.2% | 20.1% | 22.3% | 23.4% | 22.7% | 19.7% | 24.7% |
| Net profit | 30 | 35 | 43 | 47 | 51 | 56 | 43 | 53 |
| EPS ($ per share) | 1.18 | — | 1.61 | 1.74 | 1.93 | — | 1.62 | 2 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 28 | 34 | 40 | 70 | 88 | 145 | 262 | 422 |
| Total liabilities | 135 | 177 | 365 | 532 | 922 | 1,237 | 1,533 | 2,108 |
| Fixed assets | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 3 |
| Total assets | 231 | 395 | 729 | 926 | 1,306 | 1,708 | 2,262 | 3,051 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 23 | 45 | 57 | 88 | 170 | 116 | 261 | 409 |
| Cash from investing | -25 | -83 | -185 | -58 | -157 | -128 | -306 | -354 |
| Cash from financing | 2 | 62 | 128 | -13 | 5 | -4 | 74 | -29 |
| Net cash flow | -1 | 23 | 0 | 17 | 18 | -16 | 29 | 26 |
| Capital expenditure | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Free cash flow | 22 | 44 | 57 | 88 | 169 | 116 | 261 | 409 |
Insider filings
154 filings between Oct 21, 2025 and Sep 21, 2026.
Open market
decisions to buy or sellPurchases
$135
1 purchase by 1 insider
Sales
$22.01M
93 sales by 7 insiders
57% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 8
- Award — granted as compensation
- 51
- Option exercise — converted options into shares
Also filed: 1 gift.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Armstrong Mac | — | $17.23M | Sep 21, 2026 |
| Christianson Jon | — | $2.94M | Aug 18, 2026 |
| Uchida T Christopher | — | $872.6K | Aug 18, 2026 |
| Knutzen Jonathan | — | $408.2K | Aug 18, 2026 |
| Grant Angela L. | — | $253.6K | Jan 31, 2026 |
| Herve Rodolphe | — | $215.2K | Jul 31, 2026 |
| Carter Timothy | — | $90.7K | Jun 28, 2026 |
| Bradley Daryl | $135 | — | Sep 2, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | Armstrong Mac CEO and Chairman | Sale 10b5-1 plan | 1,400 | $189.8K |
| Sep 21, 2026 | Armstrong Mac CEO and Chairman | Sale 10b5-1 plan | 2,100 | $282.7K |
| Sep 2, 2026 | Bradley Daryl Director | Purchase | 1 | $135 |
| Aug 21, 2026 | Armstrong Mac CEO and Chairman | Sale 10b5-1 plan | 792 | $104.0K |
| Aug 21, 2026 | Armstrong Mac CEO and Chairman | Sale 10b5-1 plan | 369 | $47.8K |
| Aug 21, 2026 | Armstrong Mac CEO and Chairman | Sale 10b5-1 plan | 2,339 | $305.2K |
| Aug 18, 2026 | Uchida T Christopher Chief Financial Officer | Option exercise | 1,530 | $0 |
| Aug 18, 2026 | Christianson Jon President | Sale | 528 | $67.5K |
| Aug 18, 2026 | Uchida T Christopher Chief Financial Officer | Sale | 791 | $101.0K |
| Aug 18, 2026 | Knutzen Jonathan Chief Risk Officer | Sale | 296 | $37.8K |
| Aug 18, 2026 | Knutzen Jonathan Chief Risk Officer | Option exercise | 612 | $0 |
| Aug 18, 2026 | Christianson Jon President | Option exercise | 1,020 | $0 |
| Jul 31, 2026 | Herve Rodolphe Chief Operating Officer | Sale | 818 | $110.7K |
| Jul 31, 2026 | Herve Rodolphe Chief Operating Officer | Sale | 389 | $52.7K |
| Jul 31, 2026 | Herve Rodolphe Chief Operating Officer | Option exercise | 1,077 | $0 |
| Jul 31, 2026 | Herve Rodolphe Chief Operating Officer | Option exercise | 1,991 | $0 |
| Jul 21, 2026 | Armstrong Mac CEO and Chairman | Sale 10b5-1 plan | 2,103 | $287.5K |
| Jul 21, 2026 | Armstrong Mac CEO and Chairman | Sale 10b5-1 plan | 200 | $27.9K |
| Jul 21, 2026 | Armstrong Mac CEO and Chairman | Sale 10b5-1 plan | 260 | $36.0K |
| Jul 21, 2026 | Armstrong Mac CEO and Chairman | Sale 10b5-1 plan | 937 | $129.1K |
| Jul 20, 2026 | Christianson Jon President | Option exercise 10b5-1 plan | 3,000 | $262.5K |
| Jul 20, 2026 | Christianson Jon President | Sale 10b5-1 plan | 3,000 | $418.5K |
| Jul 15, 2026 | Armstrong Mac CEO and Chairman | Sale | 57,544 | $7.58M |
| Jul 15, 2026 | Armstrong Mac CEO and Chairman | Option exercise | 6,250 | $0 |
| Jul 15, 2026 | Armstrong Mac CEO and Chairman | Option exercise | 112,500 | $0 |
| Jul 15, 2026 | Armstrong Mac CEO and Chairman | Sale | 3,197 | $420.9K |
| Jul 2, 2026 | Christianson Jon President | Option exercise 10b5-1 plan | 2,434 | $120.6K |
| Jul 2, 2026 | Christianson Jon President | Sale 10b5-1 plan | 4,429 | $617.8K |
| Jul 2, 2026 | Christianson Jon President | Option exercise 10b5-1 plan | 4,429 | $387.6K |
| Jul 2, 2026 | Christianson Jon President | Sale 10b5-1 plan | 2,434 | $339.5K |
| Jun 28, 2026 | Carter Timothy Chief People Officer | Option exercise | 820 | $0 |
| Jun 28, 2026 | Carter Timothy Chief People Officer | Sale | 180 | $22.4K |
| Jun 28, 2026 | Carter Timothy Chief People Officer | Sale | 300 | $37.3K |
| Jun 28, 2026 | Carter Timothy Chief People Officer | Option exercise | 492 | $0 |
| Jun 22, 2026 | Armstrong Mac CEO and Chairman | Sale 10b5-1 plan | 2,005 | $226.0K |
| Jun 22, 2026 | Armstrong Mac CEO and Chairman | Sale 10b5-1 plan | 1,495 | $169.4K |
| Jun 2, 2026 | Notaras Martha Director | Option exercise | 1,722 | $100.0K |
| May 21, 2026 | BEISER SCOTT L Director | Award | 869 | $0 |
| May 21, 2026 | Fallon Catriona M. Director | Award | 1,304 | $0 |
| May 21, 2026 | Taketa Richard H Director | Award | 1,304 | $0 |
| May 21, 2026 | Notaras Martha Director | Award | 1,304 | $0 |
| May 21, 2026 | Middleton Daina Director | Award | 1,304 | $0 |
| May 21, 2026 | BRADLEY THOMAS A Director | Award | 1,304 | $0 |
| May 21, 2026 | Bradley Daryl Director | Award | 1,304 | $0 |
| May 21, 2026 | BEISER SCOTT L Director | Award | 1,304 | $0 |
| May 21, 2026 | Armstrong Mac CEO and Chairman | Sale 10b5-1 plan | 2,172 | $249.1K |
| May 21, 2026 | Armstrong Mac CEO and Chairman | Sale 10b5-1 plan | 1,328 | $151.3K |
| May 18, 2026 | Knutzen Jonathan Chief Risk Officer | Option exercise | 612 | $0 |
| May 18, 2026 | Uchida T Christopher Chief Financial Officer | Sale | 783 | $90.2K |
| May 18, 2026 | Uchida T Christopher Chief Financial Officer | Option exercise | 1,530 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Palomar Holdings, Inc.
Free account. Everything above stays public.
Write why you follow Palomar Holdings, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading